Helen Rizos

42PUBLICATIONS
85CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 15, 2026
Analytical Performance of the Avida Duo Assay for Simultaneous Mutation and Methylation Profiling in Circulating Cell-Free DNA.

|Apr 10, 2026
Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma.

Mal Irvine, Ashleigh Stewart, Bernadette Pedersen

|Mar 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Andrea Boutros, Matteo S Carlino, Raja Chaganti

|Mar 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Jesse R Brown, Bernadette Pedersen, Georgina V Long

|Nov 26, 2025
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma.

Fei Yang, Su Yin Lim, Ines Pires da Silva

|Jul 11, 2025
COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway.

Ada Ndoja, Christopher M Rose, Eva Lin

Pageof 7

Frequent Collaborators

14 joint publications

Georgina V Long

12 joint publications

Richard F Kefford

9 joint publications

Russell J Diefenbach

6 joint publications

Jenny Lee